Last updated on September 2018

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of X4P-001 in Patients With WHIM (Warts, Hypogammaglobulinemia, Infections and Myelokathexis) Syndrome

Brief description of study

The overall objective is to evaluate X4P-001 in the treatment of patients with WHIM Syndrome.

Clinical Study Identifier: TX212722

Find a site near you

Start Over